نتایج جستجو برای: sensitizing agents

تعداد نتایج: 364127  

Journal: :Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology 2015
Ly-Binh-An Tran Anne Bol Daniel Labar Thanh-Trang Cao-Pham Bénédicte Jordan Vincent Grégoire Bernard Gallez

PURPOSE To assess the predictive value of hypoxia imaging by (18)F-FAZA PET in identifying tumors that may benefit from radiotherapy combined with nimorazole, a hypoxic radiosensitizer. MATERIAL AND METHODS Rats of two tumor models (Rhabdomyosarcoma and 9L-glioma) were divided into two treated groups: radiotherapy (RT) alone or RT plus nimorazole. (18)F-FAZA PET images were obtained to evalua...

2005
Eric B. Kmiec

Single stranded DNA oligonucleotides have been used to direct the correction of point mutations in mammalian cells. The introduction of a single-stranded oligonucleotide sets in motion a cascade of events that eventually leads to a stalling of DNA replication forks, which enables the oligo-mediated correction event to occur more readily. This is due to the fact that cells in S phase are more am...

Journal: :Anticancer research 2014
Masataka Oita Yoshihiro Uto Masahide Tominaga Motoharu Sasaki Yasuo Hara Taro Kishi Hitoshi Hori

BACKGROUND/AIM The aims of this study were to evaluate the cell survival uncertainty distribution of radiation and to assess the accuracy of predictions of tumor response by using three different in vitro experimental cell cultures with radiosensitizers (including etanidazole). MATERIALS AND METHODS Using EMT6 cells and X-rays, the cell survival fraction was obtained from 15, 34, and 21 diffe...

2010
Kamlesh Passi Than S Kehwar Meenakshi Mittal Bikramjit Singh Rajesh Vashistha Sureshchandra J Gupta JV Yakhmi

PURPOSE To analyze the effectiveness of biologically effective dose (BED) in two different regimens of HDR brachytherapy keeping the same total BED to point A and to compare the relationship of overall treatment time in terms of local control and bladder and rectal complications. MATERIAL AND METHODS The study included two groups comprising a total of 90 cervical cancer patients who underwent...

Journal: :Chemical communications 2015
G Seeta Rama Raju Leah Benton E Pavitra Jae Su Yu

Although much progress has been made in treating cancers, cancer death rates in and around the United States are still high. Current treatments are either ineffective against some cancers or detrimental to patients, which decreases their quality of life. The use of nanotechnology in cancer therapy can potentially increase patient survival, reduce side effects, and reduce mortality rates because...

2011
Thomas Efferth Peter Langguth

Radiotherapy and radiology have been indispensable components in cancer care for many years. The detection limit of small tumor foci as well as the development of radio-resistance and severe side effects towards normal tissues led to the development of strategies to improve radio-diagnostic and -therapeutic approaches by pharmaceuticals. The term "radiopharmaceutical" has been used for drugs la...

Journal: :Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1999
M Pruschy C Wirbelauer C Glanzmann S Bodis W Krek

Negative regulation of E2F-1 DNA binding function by cyclin A kinase represents part of an S-phase checkpoint control system that, when activated, leads to apoptosis. In this study, we examined the cellular sensitivity and resistance of isogenic mouse fibrosarcoma cell lines, differing primarily in their p53 status, to ectopic expression of wild-type (wt) E2F-1 and cyclin A kinase binding-defec...

2011
Seiji Mabuchi Tadashi Kimura

Despite the recent advances in the management of cervical cancer using cisplatin-based concurrent chemoradiotherapy, substantial treatment failure still occurs, especially in advanced-stage patients and early-stage cervical cancer patients with high-risk prognostic factors. Therefore, efforts to further improve the survival and quality of life of these patients are necessary. Nedaplatin (cis-di...

Journal: :Cancer research 2011
Mengxian Zhang Susanne Kleber Manuel Röhrich Carmen Timke Na Han Jochen Tuettenberg Ana Martin-Villalba Juergen Debus Peter Peschke Ute Wirkner Michael Lahn Peter E Huber

Glioblastoma multiforme (GBM) is a highly aggressive primary brain tumor that tends to be resistant to the ionizing radiotherapy used to treat it. Because TGF-β is a modifier of radiation responses, we conducted a preclinical study of the antitumor effects of the TGF-β receptor (TGFβR) I kinase inhibitor LY2109761 in combination with radiotherapy. LY2109761 reduced clonogenicity and increased r...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید